Articles tagged with Chronic Obstructive Pulmonary Disease
A nationwide study in Singapore found that short-term increases in fine-particle air pollution are associated with more asthma and chronic obstructive pulmonary disease (COPD)-related emergency department visits. The study analyzed 6.5 years of national air quality data and found a clear relationship between PM2.5 levels and admissions.
Love Your Lungs Day draws attention to the critical importance of respiratory health in Phoenix residents, with over 410,000 cases of adult asthma and 187,000 cases of COPD in Maricopa County. The event aims to promote education, research, prevention, and access to quality respiratory care.
A five-year project led by UC Riverside researcher Erica Heinrich seeks to improve respiratory care for patients with conditions like COPD and those on mechanical ventilation. The study aims to develop a machine-learning algorithm that can predict respiratory comfort more accurately than physicians' estimates.
A Phase 3 clinical trial showed tozorakimab reduced moderate-to-severe COPD exacerbations by 29-34% compared to placebo, impacting a broad COPD population. The therapy's safety profile was generally comparable to placebo, with injection-site reactions being more frequent.
A new study found that weight loss injection semaglutide may reduce asthma attacks by up to 40% in people with airways diseases like asthma and COPD. Semaglutide also led to a 20% reduction in COPD flare-ups.
A clinical trial shows that laughter therapy can reduce breathing difficulties and is as effective as traditional breathing exercises in COPD patients. Patients who underwent laughter therapy had less difficulty breathing and better overall health compared to those who received traditional breathing exercises or no treatment.
A new study found that babies born with a higher genetic risk for COPD showed reduced lung function growth between birth and six years old, especially in areas with high air pollution. This suggests that early-life environment, including air pollution, may contribute to the foundations of the disease.
A study found that overuse of reliever inhalers increases the risk of cardiovascular disease, including heart failure, heart attack, and ischemic stroke, in asthma and COPD patients. Using three or more inhalers per year is associated with increased risk of death, particularly in patients without a prior history of cardiovascular disease.
A large population-based study found that emergency diagnoses are common across multiple conditions, including Parkinson’s disease and coronary heart disease, and are consistently associated with worse outcomes. The study suggests that emergency diagnosis is a common phenomenon across diverse diseases and is linked to higher mortality ...
A multidisciplinary project combines computer modeling, particle science, and pharmaceutical science to create more effective inhalers for people who can't inhale deeply. Researchers found that improved designs can reduce deposition in the mouth and throat, increase penetration of particles into the lungs.
A new study published in the Annals of the American Thoracic Society found that nearly one-third of COPD patients demonstrate unacceptable inhaler technique, leading to smaller lung function improvements. Instructing patients to hold their breath for 5-10 seconds improves acute bronchodilation.
A study led by Erica Heinrich highlights a critical gap in detecting and treating breathing discomfort or dyspnea in ventilated patients. Dyspnea is often hard to recognize, but carbon dioxide levels may be more significant drivers of breathlessness than oxygen levels.
Researchers developed an app to monitor daily voice changes, which can detect early signs of exacerbations in asthma and COPD. By analyzing tone, pitch, pauses, and voice quality, the TACTICAS study found that voice deteriorates as symptoms worsen, allowing for potential treatment.
Research suggests that inhaled vitamin D can protect against dust, pollution, and pathogens in the lungs, potentially improving outcomes for those with chronic lung disease. Human clinical trials are needed to confirm these findings and explore the therapeutic benefits of direct lung delivery.
A new study reveals gaps in wildfire smoke education among people living with COPD. Researchers found that many individuals rely on smartphone apps and online information for air quality updates, but lack knowledge on mitigation strategies and real-time guidance from healthcare teams.
A study found that walking in areas with high soot concentrations increases cough and mucus production in people with COPD. However, physical activity remains advisable for those with the condition, as long as busy roads are avoided.
Researchers at UTHealth Houston identified hidden systemic inflammation in patients with primary ciliary dyskinesia using a simple oral swab. This approach enables easier monitoring and could lead to more personalized treatment of other chronic lung conditions.
A new study published at ATS 2026 International Conference found that many patients who initially struggle to meet CPAP usage thresholds continue to use and benefit from the therapy. The research challenges long-held assumptions about CPAP adherence, suggesting that early struggles don't predict treatment failure.
A major new study has found that severe asthma patients are often battling other health conditions, with nearly all suffering from at least one major issue. The study identified three distinct profiles linked to how well asthma is controlled and the treatments needed, offering potential breakthroughs for improving care.
A cohort study found chronic obstructive pulmonary disease (COPD) associated with reduced life expectancy. Adults with COPD had shorter lifespans compared to those without the condition, regardless of smoking history.
A phone-based teach-to-goal program improved correct inhaler use in Medicare Advantage beneficiaries with COPD. The study found that nearly 40% of participants used their inhaler incorrectly initially, but after the program, only about 7% were incorrect, resulting in a significant reduction.
A recent study found that people with higher isoflavone consumption experienced fewer breathing-related symptoms and improved lung health. Isoflavones, commonly found in legumes and soy-based foods, may play a key role in reducing COPD symptoms.
A new study by UC San Francisco reveals that aging lung tissue can lead to catastrophic immune dysregulation, causing elderly individuals to become severely ill. The research suggests that targeting the damaged spiral of inflammaging could provide a promising therapeutic target for treating age-related respiratory diseases.
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) and the Global Lung Function Initiative (GLI) have agreed on diagnostic criteria for COPD, aiming to improve diagnosis and treatment. The new guidelines will help reduce the number of undiagnosed cases and promote the use of spirometry tests.
Researchers found that patients with both COPD and sleep apnea had significantly lower muscle strength and functional capacity compared to those with isolated COPD. The study highlights the importance of monitoring sleep-disordered breathing in the COPD population to improve quality of life.
New studies reveal that medication nonadherence in people with chronic obstructive pulmonary disease (COPD) is often caused by affordability and limited understanding of medications. This can lead to quicker lung function decline, more frequent exacerbations, and a higher symptom burden.
Researchers found that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are not only less harmful to the environment but can also lead to slightly better patient outcomes. The dry powder inhaler was associated with a 14% lower risk of moderate or severe COPD exacerbations compared to metered-dose inhalers.
A new study reveals that neighborhood characteristics, including poverty and lower educational attainment, are associated with higher COPD-related emergency department visits and hospitalizations. Community-level interventions targeting these risk factors can help improve quality of life and reduce acute care use.
New research suggests that inhaled microplastics can cause inflammation and damage to the lungs, potentially increasing the risk of respiratory diseases such as asthma and COPD. Microplastics can also trigger inflammatory responses and deliver toxins directly into the lungs, highlighting a growing concern for lung health.
The American College of Chest Physicians (CHEST) received the 2025 Glenview Environmental Sustainability Award for Innovation, recognizing its commitment to clean energy and reduced emissions. The organization's solar panel installation at its headquarters powers medical simulation facilities using renewable energy.
A recent study by King's College London found that diagnosis rates for depression, asthma, and osteoporosis remained lower than expected after the COVID-19 pandemic. The study analyzed data from over 29 million people in England and found that diagnosis rates recovered differently across ethnic and socioeconomic groups.
The American College of Chest Physicians released a new clinical guideline on biologic management in severe asthma. The guideline provides evidence-based recommendations for selecting biologics for different patient populations, considering factors such as baseline oral corticosteroid use and comorbid conditions.
Researchers at Mount Sinai have developed an AI-powered ECG analysis tool that shows promise in detecting Chronic Obstructive Pulmonary Disease (COPD) early. The model achieved high accuracy rates across diverse populations, including a subgroup with irregular heartbeat and smoking exposure.
The UN has pledged to improve access to diagnosis and treatment for chronic obstructive pulmonary disease (COPD), which affects 480 million people worldwide. Inhaled medicines can reduce health and economic costs associated with COPD, but only 7% of pharmacies in low- and middle-income countries currently offer them.
A monthly injection has helped 90% of severe asthma patients reduce their reliance on daily steroid tablets. Treatment with tezepelumab improved asthma symptoms, lung function, and overall quality of life, with two-thirds of patients experiencing no asthma attacks.
A European consortium developed a new decision-making framework to predict COPD exacerbation severity and prognostic risk, integrating three key factors: baseline health status, event intensity, and triggers. This framework, known as BAt model, aims to guide treatment strategies and improve consistency across clinical settings.
The new system can reveal early cancers, lung disease, hidden material defects and changes in porosity without multiple exposures or complex mechanical movement. This method produces low-dose and faster images, lowering patients' radiation dose and making clinical translation feasible.
A cross-sectional survey of 29,268 participants found a significant association between dysfunctional breathing and respiratory conditions, as well as non-respiratory diseases like epilepsy. Tobacco use was also linked to increased prevalence of DB, particularly among those with comorbidities.
World COPD Day on November 19 highlights the significance of correctly diagnosing chronic obstructive pulmonary disease (COPD) earlier. Up to 70% of adults with COPD remain undiagnosed, leading to poorer quality of life and health outcomes. Active case finding through spirometry can improve diagnosis and treatment.
A cross-sectional study investigated the relationship between systemic immune-inflammation index (SII) and in-hospital mortality in ICU patients with chronic obstructive pulmonary disease (COPD) and atrial fibrillation (AF). The results showed a nonlinear association between SII and in-hospital mortality, with higher SII values associa...
The study demonstrated that nebulized HL231 at 261 µg/141 µg dose achieved comparable bronchodilation efficacy, pharmacokinetic profiles, and safety outcomes to Ultibro. HL231 showed a clear dose-response relationship with predominantly mild-to-moderate adverse events.
This study evaluates the effectiveness of staged versus simultaneous bilateral lung volume reduction surgery in patients with severe emphysema. Both approaches significantly improve pulmonary function tests, but the staged approach offers a better composite outcome of overall survival and transplant-free survival.
A CT-based whole-lung radiomic nomogram accurately identifies AECOPD, offering a robust tool for clinical diagnosis and treatment planning. The nomogram demonstrated near-equivalent diagnostic performance to the radiomic score model, surpassing that of the clinical model.
A new Northwestern University study reveals that abnormal cells in transplanted lungs engage in harmful 'conversations' with the immune system, leading to damage and rejection. The findings provide a comprehensive roadmap for treating chronic lung allograft dysfunction and other scarring lung diseases.
The analysis of 2024 English voting patterns suggests that poorer health is associated with higher proportions of votes for Reform UK. This finding highlights the need for policymakers to address health inequalities and improve public health.
The American College of Chest Physicians has designated October 19, 2025, as 'Love Your Lungs Day' in recognition of respiratory health. This initiative aims to raise awareness about lung diseases such as asthma and COPD, promoting equity and supporting healthcare providers.
Researchers aim to determine if biomarkers can identify adults at risk of developing interstitial lung disease (ILD), a chronic condition that causes inflammation and scarring in the lung tissue. The approach could lead to the development of new, better treatments with more tolerable side effects.
A pilot study found that hypnosis significantly improved patients' tolerance of masks, allowing them to breathe more comfortably. The study showed a substantial improvement in non-invasive ventilation (NIV) tolerance, reduced agitation, and lower requirements for sedation and anti-anxiety medication.
A gold-standard randomised-controlled trial found that specialised singing programmes can improve the symptoms and quality of life of people with lung disease, particularly those with chronic breathlessness. The SINFONIA study showed a significant improvement in quality of life for patients with COPD and ILD.
A new study found that inhaling marijuana daily is associated with a 44% increased chance of developing asthma. Experts say people should avoid inhaling cannabis to reduce the risk of chronic lung disease. The study's authors emphasize the need for clearer messages about the risks of cannabis use.
A new study shows that implementing a COPD care pathway can lead to shorter hospital stays, more referrals to pulmonary rehabilitation, and improved standardization of care. The study found that patients treated with the pathway had better outcomes, including being discharged home rather than to a facility.
People with schizophrenia are more likely to develop chronic obstructive pulmonary disease (COPD) due to shared genetic, socioeconomic, and environmental factors. The lack of adequate medical care also contributes to the under-diagnosis of COPD in this population.
A study found that patients who communicate with their providers have better disease management, reducing exacerbations and hospital visits. The study suggests increasing conversations about disease education and self-management strategies can improve quality of life.
A new study will investigate whether low levels of the lung protein CC16 in childhood can predict who will develop early chronic obstructive pulmonary disease (COPD) later in life. The five-year study aims to identify children at risk for early COPD and potentially intervene to prevent lung disease.
A new study published in Aging-US found that frailty is associated with increased respiratory exacerbations and mortality in individuals with a history of cigarette smoking. Frail participants had a three- to five-fold higher chance of developing serious or frequent respiratory attacks, even if they had normal lung function.
A new diagnostic schema for COPD improves patient identification by incorporating CT lung imaging and respiratory symptoms. This approach identified additional individuals at risk of poor respiratory outcomes and excluded those with airflow obstruction without respiratory symptoms.
The BREATHE-3 clinical trial evaluates a novel bronchoscopic device to open airways and release trapped air in patients with severe emphysema. The study will assess the safety and efficacy of the Apreo BREATHE Airway Scaffold, an implantable device granted FDA Breakthrough Device Designation.
The project aims to develop novel, interpretable biomarkers using advanced artificial intelligence to overcome limitations in current diagnostic tools. The team will integrate multi-modal data and biomechanics for better diagnosis and tracking of chronic obstructive pulmonary disease (COPD).
Researchers found that certain antiviral genes become less active with age in people with lupus, leading to fewer inflammatory proteins. This reversal of 'inflammaging' may explain why symptoms improve in some older patients, allowing them to approach healthy aging.
Scientists successfully generated lung cells similar to alveolar epithelial type 2 (AT2) cells from mouse embryonic fibroblasts without using stem cell technology. The AT2-like cells were generated in just 7 to 10 days, a significant reduction compared to conventional methods.